1. Home
  2. ISPR vs RPID Comparison

ISPR vs RPID Comparison

Compare ISPR & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ispire Technology Inc.

ISPR

Ispire Technology Inc.

HOLD

Current Price

$1.32

Market Cap

85.5M

Sector

Health Care

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$1.12

Market Cap

84.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISPR
RPID
Founded
2010
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.5M
84.8M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
ISPR
RPID
Price
$1.32
$1.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.50
★ $8.00
AVG Volume (30 Days)
22.3K
★ 295.6K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 15.94
2.78
EPS
N/A
N/A
Revenue
★ $96,014,610.00
$33,587,000.00
Revenue This Year
N/A
$19.12
Revenue Next Year
$14.31
$18.42
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 19.74
52 Week Low
$1.01
$1.09
52 Week High
$3.87
$4.94

Technical Indicators

Market Signals
Indicator
ISPR
RPID
Relative Strength Index (RSI) 41.61 25.43
Support Level $1.19 N/A
Resistance Level $1.98 $2.18
Average True Range (ATR) 0.13 0.07
MACD -0.01 0.01
Stochastic Oscillator 21.97 10.17

Price Performance

Historical Comparison
ISPR
RPID

About ISPR Ispire Technology Inc.

Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: